Biostar Beta. Not for public use.
Whether it's right that we should choose different MSI locis for different cancer types if using NGS dectect MSI status?
Entering edit mode
14 months ago
demolidd77 • 0


As we know ,there has differenct MSI-H prevalence for different cancer types . So if we wanna use NGS method to detect MSI status of tumor samples, should we consider to pick particular and specific MSI loci combination for one specific cancer ? and why ?

Becasue different cancers have different driver genes , should we choose MSI loci within the range of driver genes ? and why ?

what's the best method to pick MSI loci to determine the tumor sample MSI-H status ?

Any help is welcome ! Thanks !


Login before adding your answer.

Similar Posts
Loading Similar Posts
Powered by the version 2.3